Austin Biotech Firm XBiotech USA, Inc. Begins Construction On $200 Million Campus

XBiotech USA Inc., an emerging Austin drug developer, will break ground Friday on the first manufacturing and research facility at its 48-acre siteoff Riverside Drive in Southeast Austin that is expected to eventually house a $200 million campus of buildings.

The 46,0000-square-foot building will cost “no more than $12 million,” company President and CEO John Simard told Austin Business Journal. Construction is expected to finish by mid-2015 and start manufacturing and shipping the company’s colorectal cancer-fighting drug Xilonix by early 2016. That drug is currently going through Phase 3 trials in the U.S. and Europe.

Help employers find you! Check out all the jobs and post your resume.